Vitamin D2 supplements may lower your natural vitamin D levels, study finds

The vitamin D supplement section at any pharmacy is a quiet argument about equivalence. Vitamin D2 and vitamin D3 are both sold as vitamin D, both recommended for bone health and immune function, and both typically labeled simply as vitamin D without further distinction. A new meta-analysis published in Nutrition Reviews suggests that distinction matters more than anyone told you — and that millions of people taking the wrong form may be making their vitamin D status worse, not better. ScienceDaily

The study, led by Emily Brown and colleagues at the University of Surrey along with researchers at the John Innes Centre and Quadram Institute Bioscience, analyzed data from randomized controlled trials and found that people taking vitamin D2 supplements ended up with lower concentrations of vitamin D3 in their blood than people who took nothing at all. In many of the studies reviewed, the vitamin D2 group finished with worse vitamin D status than the control group. The mechanism is not fully established, but the pattern was consistent enough across trials to prompt the researchers to describe it as a previously unknown effect of vitamin D2 supplementation. ScienceDaily

This is not the same as saying D2 simply raises vitamin D less efficiently than D3, which has been debated for years. It is worse than that. D2 appears to reduce the body's existing D3, the form the body makes from sunlight and uses most effectively to raise overall vitamin D levels. A prior study by the same Surrey group, published in Frontiers in Immunology in 2022, offers a partial explanation: only vitamin D3 appears to stimulate the type I interferon signaling system, a key part of the immune system that provides a first line of defense against bacteria and viruses. Vitamin D2 did not produce the same effect. The new meta-analysis adds the population-level evidence, RCT data, that the 2022 study lacked. Frontiers in Immunology

The broader biological picture supports the concern. Vitamin D2 binds to the vitamin D binding protein in the bloodstream with lower affinity than D3 and is cleared from the body more quickly, according to the Frontiers paper. The two forms share a common receptor but are not processed equivalently. Brown's team concluded that subject to individual considerations, vitamin D3 supplements may be more beneficial for most individuals than vitamin D2. Frontiers in Immunology

The practical stakes are large. Vitamin D deficiency is considered a significant public health concern in the UK, particularly during winter months when the body cannot synthesize it from sunlight. Government guidance recommends 10 micrograms of supplement daily, especially between October and March. But many supplements, particularly those marketed as suitable for vegans since D2 is derived from irradiated fungi rather than animal sources, contain D2 as their primary form. If you have been taking a vegan vitamin D supplement assuming it was equivalent to the form your skin makes from sunlight, the evidence suggests you may have been running a deficit without realizing it. ScienceDaily

The question of whether D2 and D3 are functionally equivalent has been contested in nutrition science for years. Some authorities treated them as interchangeable; others noted that D3 consistently outperformed D2 in head-to-head trials for raising serum 25-hydroxyvitamin D, the standard biomarker for vitamin D status. The ScienceDaily story reporting the Surrey meta-analysis on May 23, 2026 frames the finding as a warning about a previously unknown downside, which is accurate if slightly delayed, since the Nutrition Reviews paper itself appears to have been published in 2025. The 2022 Frontiers study already showed the interferon mechanism. The meta-analysis provides the RCT-level synthesis that gives the concern real weight. Nutrition Reviews

The implications extend beyond the supplement aisle. The global vitamins and supplements market was estimated at roughly $164 billion in 2025, according to Fortune Business Insights, and vitamin D supplements are among the most widely used products in the category. If D2 is not merely less effective than D3 but actively counterproductive, depleting the body's preferred form while failing to trigger the immune signaling that D3 uniquely provides, then the industry's quiet standardization on D2 for cost and sourcing reasons deserves scrutiny. The form that is cheaper to produce and easier to source from plant sources has been sold as equivalent to the form the human body evolved to make from sun exposure. The new research suggests that equivalence assumption was wrong in a direction that matters for immune function.

The researchers are careful about what their findings prove. The meta-analysis establishes that D2 reduces circulating D3 and that D3 stimulates interferon signaling in ways D2 does not. It does not prove that taking D2 supplements causes worse health outcomes in the way the biomarker changes suggest it might. Connecting the mechanistic dots to clinical end points, higher infection rates, worse respiratory outcomes, would require different and longer studies. But the direction of the evidence is consistent, and the researchers argue that further investigation into the distinct physiological roles of D2 and D3 should be a priority. Nutrition Reviews Frontiers in Immunology

The supplement industry has operated for years on the assumption that naming a molecule means understanding it. Vitamin D is vitamin D, the logic goes, regardless of which fungus or fish oil it came from. Biology, as it tends to, is more particular than the label suggests.